Navigation Links
Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark
Date:2/15/2011

PALO ALTO, Calif., Feb. 15, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna™ Aneurysm Embolization System (AES) received CE Mark for the treatment of patients with brain aneurysms.  The Luna AES is designed to be a single-deployment, easy-to-use system for the treatment of brain aneurysms both pre- and post-rupture.  

"Brain aneurysm treatment historically has been the domain of either surgery or, more recently, catheter-placed wire coils," said Eric Milledge, CEO, Nfocus Neuromedical.  "Surgery can be traumatic and expensive, and coils may fail to fully treat an aneurysm.  The Luna AES represents a dramatic step forward in the treatment of these patients."

It is estimated that up to one in 15 people will develop a brain aneurysm during their lifetime.(1)  Rupture of an aneurysm can cause stroke, brain damage and even death.

The Luna AES treats brain aneurysms by blocking (embolizing) blood flow while providing a scaffold to encourage tissue growth across an aneurysm opening and create a plug. The Luna uses a self-expandable, multi-layer oval implant made from Nitinol, a nickel-titanium alloy. The properties of the device allow it to easily compress within a conventional catheter, and then rapidly and easily open to full size once deployed within an aneurysm.

"CE Mark approval is an important milestone for Nfocus," said Robert O'Holla, vice president of regulatory affairs, Nfocus Neuromedical.  "The Luna AES is our flagship product and we look forward to working with physicians and hospitals in Europe to advance this important new technology."

About Nfocus Neuromedical, Inc.

Nfocus is developing the next generation treatment for brain aneurysms. The company's innovative LUNA™ product is a single-deployment, easy-to-use embolization device designed to be a direct replacement to detachable coils. Nfocus is backed by three major U.S.- and OUS-based venture funds: DFJ ePlanet Capital, Technology Partners, and InCube Ventures. Other investors include Raffles Capital and Endeavor Vision. More information can be found at www.nfocusneuro.com.

(1) - http://www.brainaneurysm.com/


'/>"/>
SOURCE Nfocus Neuromedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions
2. Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments
3. Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment
4. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
5. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
6. Valor Medical Reports Early Clinical Results of New Technology to Treat Cerebral Aneurysms
7. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
8. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
9. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
10. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
11. Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 2017 Laboratory Markets Limited has completed a ... spectrometry in both clinical and research laboratory settings. This ... size of $6.8 billion and growing to $9.2 billion ... the use of mass spectrometry across more than 5,200 ... investigated growth in the use of mass spectrometry in ...
(Date:1/23/2017)... , Jan. 23, 2017 The Pharmacy ... the implementation of the planned 2020 accredited education ... PTCB originally announced in 2013 that the requirement ... a road map of program changes designed to ... in the pharmacy. "We have ...
(Date:1/23/2017)... , Jan. 23, 2017  Based on ... Frost & Sullivan recognizes Ansell, a global leader ... & Sullivan Company of the Year Award. Ansell,s ... and a wide global footprint have placed it ... hand protection market. The Company,s established product line ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... “Spiritual Vitamins: A Spiritual ... with God. “Spiritual Vitamins: A Spiritual Energy Booster” is the creation of published ... Mathai Yohannan’s new book engages the mind and spirit in a quest for ...
(Date:1/24/2017)... ... ... “The Octagon of Spiritual Balances”: a guide for the Christian seeking ... published author, Pastor Bernard J. Weathers, pastor of Word of Faith Ministries, in Colonia, ... and a master degree in theology. , ““The Octagon of Spiritual Balances” exposes the ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... scientific article suggests that autologous fat grafting—taking one’s own fat and ... naturally, without breast implants. , Cosmetic Surgeon and Medical Director of MilfordMD ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... Friday, January 20, with the bipartisan original co-sponsorship of nearly one-quarter of the ... 12. The National Association of Chain Drug Stores (NACDS) strongly backs the legislation. ...
(Date:1/24/2017)... Washington, D.C. (PRWEB) , ... January 23, 2017 ... ... today issued the following statement on the imposition of the Mexico City Policy, ... , The policy, enacted again today through Executive action, prohibits foreign non-governmental organizations ...
Breaking Medicine News(10 mins):